BXLS Advisors is a Delaware limited liability company that was established in 2017. BXLS Advisors provides investment advisory services to Blackstone Life Sciences V L.P. and any parallel or alternative investment vehicles relating to it (collectively, “BXLS V” or the “BXLS V Funds”), Blackstone Life Sciences Yield L.P., Blackstone Life Sciences Yield T L.P. and Blackstone Life Sciences Yield NT L.P. and any parallel or alternative investment vehicles relating to it (collectively “BXLS Yield” or the “BXLS Yield Funds”) and together with BXLS V and the BXLS V Funds, the “Funds”) and certain other pooled investment vehicles that could be formed from time to time (which shall be considered Funds for purposes hereof as the context requires). BXLS V is an investment fund that specializes in structured investments in late clinical stage life sciences products, including investments in pharmaceutical, biotechnology or medical device, diagnostic and life science tools (collectively, “MedTech” and together with pharmaceutical and biotechnology, “Life Sciences”) companies, pre-approval royalties and other opportunistic Life Sciences investments, including pre-approval royalty monetizations and investments in early- stage businesses. BXLS Yield is an investment fund that specializes in Life Sciences investments in approved, cash flowing products, in particular, investments in post-approval royalties, the creation and acquisition of synthetic royalties and Life Sciences-related structured credit. Affiliates of BXLS Advisors serve as the general partners (the “General Partners”) of each of BXLS V and BXLS Yield. References herein to “the General Partner” shall mean the applicable General Partner for the applicable Fund. References throughout this Brochure to the term “Sponsor” describe, as the context or applicable law requires, individually and collectively, the General Partners and BXLS Advisors, and all references herein to the Sponsor or to any rights, powers, responsibilities, or activities of the

Sponsor are qualified in all respects by the Organizational Documents (as defined herein) of the Funds, all of which should be carefully reviewed by each potential investor in the Funds for, among other things, a more detailed description of the relative rights, powers, responsibilities and activities of each of the General Partners and BXLS Advisors. The ultimate parent of BXLS Advisors is Blackstone Inc. (together with its affiliates, “Blackstone”), which is a publicly traded corporation listed on the New York Stock Exchange and which trades under the ticker symbol “BX”. Blackstone is a leading global alternative investment manager with investment vehicles focused on private equity, real estate, hedge fund solutions, credit, infrastructure, Life Sciences, secondary funds, tactical opportunities, infrastructure and insurance solutions. Please see Item 10 – Other Financial Industry Activities and Affiliations for more information. BXLS Advisors’ regulatory assets under management was $7,184,881,378 as of December 31, 2023. Description of Advisory Services: BXLS Advisors serves as investment adviser to the BXLS V Funds and the BXLS Yield Funds pursuant to the terms of the investment advisory agreements (the “Advisory Agreements”) between BXLS Advisors and each of the BXLS V Funds and BXLS Yield Funds, and makes investment decisions for the BXLS V Funds and BXLS Yield Funds including by evaluating the BXLS V Funds’ and the BXLS Yield Funds’ investments. The individual needs of the investors in the Funds are not the basis of investment decisions by BXLS Advisors. Investment advice is provided directly to the Funds by BXLS Advisors and not individually to the Funds’ investors. Through a series of delegation agreements, BXLS Advisors also provides specific portfolio management services to certain private investment funds managed by an affiliated alternative investment fund manager for the purposes of the European Union Alternative Investment Fund Managers Directive (“AIFMD”).